Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.

Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G.

APMIS. 2006 Oct;114(10):712-9.

PMID:
17004974
2.

Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.

Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G.

Histopathology. 2005 Aug;47(2):195-201.

PMID:
16045781
5.
6.

Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.

Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G.

Mod Pathol. 2001 Aug;14(8):768-76.

8.

Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.

Luo MH, Huang YH, Ni YB, Tsang JY, Chan SK, Shao MM, Tse GM.

Hum Pathol. 2013 Jul;44(7):1241-50. doi: 10.1016/j.humpath.2012.10.009.

PMID:
23332923
10.

PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.

Pagani A, Sapino A, Eusebi V, Bergnolo P, Bussolati G.

Virchows Arch. 1994;425(5):459-65.

PMID:
7850069
11.

Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.

Chia SY, Thike AA, Cheok PY, Tan PH.

Breast. 2010 Oct;19(5):355-9. doi: 10.1016/j.breast.2010.02.007.

PMID:
20347310
12.

Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.

Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB.

Pathol Res Pract. 2008;204(6):367-71. doi: 10.1016/j.prp.2008.01.012.

PMID:
18342452
13.

Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.

Satoh F, Umemura S, Osamura RY.

Breast Cancer. 2000 Jan;7(1):49-55.

PMID:
11029771
14.
15.

Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.

Yan Z, Gidley J, Horton D, Roberson J, Eltoum IE, Chhieng DC.

Diagn Cytopathol. 2009 Jul;37(7):475-8. doi: 10.1002/dc.21039.

PMID:
19217055
16.
17.

Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.

Fritzsche FR, Thomas A, Winzer KJ, Beyer B, Dankof A, Bellach J, Dahl E, Dietel M, Kristiansen G.

Histol Histopathol. 2007 Nov;22(11):1221-30.

PMID:
17647195
18.
19.

Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?

Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Yoshikawa K, Sato Y, Aoyama H, Hayashi T, Kushima R.

Hum Pathol. 2008 May;39(5):666-71. doi: 10.1016/j.humpath.2007.09.009.

PMID:
18339419
20.

Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.

Bhargava R, Beriwal S, Dabbs DJ.

Am J Clin Pathol. 2007 Jan;127(1):103-13.

Items per page

Supplemental Content

Support Center